我爱我家

康奈利：原有望签詹姆斯 杰伦-布朗交易猝不及防_我的网站

A |     

    
    　　森林狼篮球运营总裁康奈利做客《The Jon Krawczynski Show》节目，回顾休赛期争夺勒布朗-詹姆斯的幕后故事。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。
    
    　　康奈利表示，森林狼当时确实参与了詹姆斯的争夺战。詹姆斯对和爱德华兹、戈贝尔、麦克丹尼尔斯联手打球抱有浓厚兴趣，康奈利本人和詹姆斯团队也有着长期的交情。双方多次深夜长谈，篮球战术层面的匹配度不存在障碍，詹姆斯对这套阵容体系表现得相当兴奋。

B | 不过詹姆斯对当地弗里德利啤酒厂并没有什么好感。
    
    　　但后续杰伦-布朗那笔重磅交易突然落地，这件事完全出乎森林狼的预料，局面急转直下，因此球队始终不敢抱有过高期待。
    
    　　即便如此，双方之间的联络一直保持频繁，没有出现长时间断联。詹姆斯十分向往可以在戈贝尔、麦克丹尼尔斯两名顶级防守悍将身边打球。
    
    　　康奈利坦言，詹姆斯最终选择加盟另一支实力不俗的东部队伍，对森林狼而言也算一件好事，不用在西部赛场直接面对他。森林狼当初已经竭尽所能展开招募，可惜没能如愿将其招致麾下。

Current article:http://ltzcgsz.cousizhegaobaolengkuo.bond/list_p14g7hb/8jm2dlh.html

Published on:06:53:30